+1 123-456-7890
    Formulation Of Biosimilars

    Formulation Of Biosimilars

    Biosimilars are the buzz word du jour in the biopharma arena; however, the development of biosimilars that will truly provide cost savings that the end consumer typically expects of a “generic” drug product is the real challenge due in part to the following reasons:

    • The lack of a centralized listing of biological patents (like the Orange Book) and company analysis is kept confidential
    • Platform patents protect broad groups of products, e.g. humanized antibodies, which are not product specific
    • And formulation patents